Credit Agricole
ALNY icon

Credit Agricole’s Alnylam Pharmaceuticals ALNY Stock Holding History

Credit Agricole’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.23M Sell
10,731
-1,020
-9% -$308K 0.01% 850
2026
Q1 		$3.89M Sell
11,751
-9,789
-45% -$3.33M 0.01% 682
2025
Q4 		$8.57M Buy
21,540
+9,173
+74% +$4.06M 0.02% 462
2025
Q3 		$5.64M Buy
+12,367
New +$5.04M 0.01% 524
2025
Q1 		$888K Sell
3,287
-706
-18% -$181K ﹤0.01% 942
2024
Q4 		$940K Buy
3,993
+1,310
+49% +$345K ﹤0.01% 946
2024
Q3 		$738K Buy
2,683
+110
+4% +$28.6K ﹤0.01% 868
2024
Q2 		$625K Buy
+2,573
New +$406K ﹤0.01% 807
2021
Q3 		– Sell
-150
Closed -$25K – 668
2021
Q2 		$25K Hold
150
– – ﹤0.01% 557
2021
Q1 		$21K Buy
+150
New +$22.6K ﹤0.01% 522
2017
Q2 		– Sell
-1,613
Closed -$83K – 1419
2017
Q1 		$83K Sell
1,613
-1,703
-51% -$78.7K ﹤0.01% 1574
2016
Q4 		$125K Sell
3,316
-10,030
-75% -$420K ﹤0.01% 1372
2016
Q3 		$905K Buy
13,346
+522
+4% +$36.8K ﹤0.01% 1193
2016
Q2 		$711K Buy
12,824
+642
+5% +$40.4K ﹤0.01% 1094
2016
Q1 		$765K Buy
12,182
+1,270
+12% +$84.4K ﹤0.01% 981
2015
Q4 		$1.03M Sell
10,912
-1,604
-13% -$149K ﹤0.01% 999
2015
Q3 		$1.01M Buy
12,516
+2,018
+19% +$224K 0.01% 1009
2015
Q2 		$1.26M Buy
+10,498
New +$1.25M 0.01% 983

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Credit Agricole's ALNY Position: Q2 2026 in Review

Credit Agricole reduced its Alnylam Pharmaceuticals (ALNY) stake by 8.7% in Q2 2026, selling an estimated $308K and leaving 10,731 shares worth $3.23M. The position accounts for 0.01% of the portfolio, ranked #850.

Credit Agricole first reported a position in ALNY in Q2 2015 and has held it in 18 quarters since. The position peaked at $8.57M in Q4 2025. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Credit Agricole held 10,731 shares of Alnylam Pharmaceuticals worth $3.23M as of Q2 2026.
  • Credit Agricole sold 1,020 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $308K.
  • Alnylam Pharmaceuticals made up 0.01% of Credit Agricole's portfolio in Q2 2026, its #850 holding.
  • Credit Agricole first reported a position in Alnylam Pharmaceuticals in Q2 2015 and has held it in 18 quarters since.
  • Credit Agricole's Alnylam Pharmaceuticals position peaked at $8.57M in Q4 2025.
  • 785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.